Bio€quity Europe 2026 to Take Place in Prague – First Edition in Central and Eastern Europe

Bio€quity Europe 2026 to Take Place in Prague – First Edition in Central and Eastern Europe

With Prague.bio and IOCB Tech as the Regional Hosts, Europe’s leading biotech investor event comes to the Czech capital, highlighting the region’s growing role in life sciences.

Prague, Czech Republic, May 15, 2025 – Prague.bio cluster announced today that Bio€quity Europe will make its debut in Central and Eastern Europe in 2026, with the Czech capital selected to host the event. Scheduled for 4 to 6 May, the conference reflects Prague’s rising profile as a strategic gateway for investors seeking access to the region’s fast-growing life sciences ecosystem.

For 25 years, Bio€quity has been a leading industry forum that convenes biopharma executives, investors, and policymakers from more than 30 countries. The event is known for its high-level panel discussions, company presentations, and one-on-one partnering format. At the closing ceremony of this year’s conference in Bruges, Belgium, Prague was officially announced as the next host city, a landmark moment for the Czech biotech community.

The official handover took place with Prague.bio CEO Petra Kinzlová and Managing Director Jiří Fusek representing the organization as one of the event’s 2026 Regional Hosts and a key cluster for Czech life sciences. “We are truly honoured to welcome Bio€quity to Prague,” said Petra Kinzlová, CEO of Prague.bio. “This marks the first time the event will take place in the CEE region, a significant milestone that underscores our role as your biotech hub in the heart of Europe. Hosting this prestigious conference is a unique opportunity to showcase the strength and potential of the Czech biotech sector and to foster deeper cross-border collaboration within Europe’s innovation ecosystem.”

“We are hugely excited to expand Bio€quity’s footprint to Prague and Central and Eastern Europe. It once again demonstrates BioCentury’s commitment to building a truly global network for the biopharma community,” added David Flores, President & CEO of BioCentury.

"EBD Group is delighted to connect the dynamic Bio€quity Europe community with Prague's long tradition of pharmaceutical innovation. Its central location and emerging ecosystem make it an exciting first-time Bio€quity Europe host city," said Claire Macht, Director, European Portfolio, EBD Group.

A Growing Life Sciences Ecosystem

The Czech Republic combines scientific excellence with growing investor interest. It is home to nearly 400 biotech-related entities, employing over 22,000 professionals and generating more than €3 billion in annual revenue. Over 12,000 students are currently enrolled in life sciences fields, ensuring a robust talent pipeline. Since 2003, the sector has attracted €1.5 billion in foreign direct investment.

One notable example of growing investor confidence is the i&i Biotech Fund, launched in 2021 with approximately €50 million in backing from the European Investment Fund and private investors. The fund’s establishment highlights both the quality of Czech research and its commercial potential.

Bio€quity Europe 2026 is expected to bring hundreds of investors, executives, and biotech innovators to Prague for company presentations, expert discussions, and in-depth partnering. The event offers an ideal platform to further connect the region’s growing biotech sector with the broader European and global life sciences community. To register for Bio€quity Europe 2026, visit www.informaconnect.com.

About Prague.bio

Prague.bio was founded in 2023 to connect stakeholders across research, business, and government, currently the association has 30 members which include which include leading research institutes, universities, biotech start-ups and SMEs, and also large Czech and multinational enterprises.

The cluster plays an active role in strengthening the Czech biotech ecosystem by supporting technology transfer, enabling public-private collaboration, and increasing international visibility. Prague.bio also organizes the annual Prague.bio Conference, the region’s largest biotech industry meeting, with the next edition taking place on 25 September 2025.

For more information, visit www.prague.bio or follow Prague.bio on LinkedIn.